Related Experiment Video
Updated: Jul 3, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically
Sanjay Haresh Chotirmall1, Peter Branagan, Cedric Gunaratnam
1Department of Respiratory Medicine, Beaumont Hospital. Dublin 1, Republic of Ireland. sanjaychotirmall@hotmail.com
Background:
Patients with cystic fibrosis (CF) can become colonized by aspergillus, which can act as an allergen and cause allergic bronchopulmonary aspergillosis (ABPA).
Objective:
To determine the rate of aspergillus colonization and ABPA in a population of Irish patients with CF.
Methods:
In 50 consecutive patients with CF who presented with exacerbations, we looked for the presence of aspergillus in their sputum and signs and symptoms of ABPA.
Results:
Fifteen patients (30%) grew aspergillus species in their sputum cultures. Six patients (12%) had ABPA. Matched for age, sex, genotype, and microbiology, there was no significant difference in forced expiratory volume in the first second (percent predicted, FEV(1)%) in subjects with aspergillus-positive sputum compared to those not colonized with aspergillus. Subjects with ABPA experienced sharp short-term deterioration in lung function (mean 6.7% predicted FEV(1)), which returned to baseline following at least 4 weeks of treatment.
Conclusions:
The prevalence of ABPA was 12%. Aspergillus-positive sputum of itself was not a poor prognostic sign in terms of lung function over the 5-year study course. ABPA produces short-term reversible declines in lung function and responds to treatment. The frequency of aspergillus isolates did not correlate with the occurrence of ABPA. A low threshold for the diagnosis of ABPA should be maintained in any patient with CF who does not improve with antibiotics.
Insights
In Irish cystic fibrosis (CF) patients, 12% had allergic bronchopulmonary aspergillosis (ABPA). While Aspergillus colonization occurred in 30%, it did not impact long-term lung function, whereas ABPA caused temporary declines.
Area of Science:
- Pulmonology
- Infectious Diseases
- Allergy & Immunology
Background:
- Cystic Fibrosis (CF) patients are susceptible to Aspergillus colonization.
- Aspergillus acts as an allergen, potentially causing Allergic Bronchopulmonary Aspergillosis (ABPA).
Purpose of the Study:
- To determine the prevalence of Aspergillus colonization and ABPA in Irish CF patients.
- To assess the impact of colonization and ABPA on lung function.
Main Methods:
- Sputum cultures and ABPA diagnostics were performed on 50 consecutive CF patients presenting with exacerbations.
- Lung function (FEV1%) was monitored and compared between colonized and non-colonized groups, and in ABPA patients before and after treatment.
Main Results:
- Aspergillus species were found in 30% of sputum cultures.
- 12% of patients were diagnosed with ABPA.
- Aspergillus colonization did not significantly affect long-term lung function (FEV1%).
- ABPA patients experienced a short-term decline in lung function (mean 6.7% predicted FEV1) that resolved with treatment.
Conclusions:
- The prevalence of ABPA in this Irish CF cohort was 12%.
- Aspergillus colonization alone is not a negative prognostic indicator for lung function in CF.
- ABPA leads to reversible lung function decline and responds to treatment.
- A high index of suspicion for ABPA is recommended in CF patients unresponsive to antibiotics.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
